KYTX Market Cap & Key Metrics
Kyverna Therapeutics, Inc.
$5.91
+$0.22(+3.87%)
30
Overall
60
Value
10
Tech
21
Quality
Market Cap
$351.58M
Volume
433.68K
52W Range
$5.96 - $13.67
Target Price
$30.40
KYTX market cap is $351.58M. This page lists Kyverna Therapeutics, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
KYTX Key Metrics
- Market cap
- $351.58M
- EPS estimate, current year
- $-2.70
- EPS growth, 3-year
- +61.43%
- Value score
- 60
- Quality score
- 21
- Technical score
- 10
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | - | - | - | $7.03M |
| EBITDA | -$159.02M | -$125.20M | -$58.47M | - |
| EPS | $-3.64 | $-3.33 | $-89.61 | $-63.43 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KYTX | $5.91 | +3.9% | 433.68K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Kyverna Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW